Clinical Trials
59
Trial Phases
4 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
- Conditions
- Advanced Solid Tumors
- Interventions
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 177
- Registration Number
- NCT07042100
- Locations
- 🇮🇳
SPARC Investigative Site, Delhi, New Delhi, India
A Study in Patients With Advanced Breast Cancer
- Conditions
- HER2-negative Breast CancerAdvanced Breast CancerHormone Receptor-positive Breast Cancer
- Interventions
- Drug: Part 1Drug: Part 2Drug: Part 3
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 9
- Registration Number
- NCT04942054
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸The University of Chicago, Chicago, Illinois, United States
🇮🇳HealthCare Global Enterprises Ltd, Bangalore, Karnataka, India
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
- Conditions
- Locally Recurrent CancerMetastatic Breast Cancer
- Interventions
- Drug: PICS (Reconstitution Method 1 or 2)
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2020-06-01
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Registration Number
- NCT04332549
- Locations
- 🇮🇳
SPARC Site 12, Visakhapatnam, Andhra Pradesh, India
🇮🇳SPARC Site 21, Ahmadabad, Gujarat, India
🇮🇳SPARC Site 22, Sūrat, Gujarat, India
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 140
- Registration Number
- NCT04242953
- Locations
- 🇺🇸
AXIS Clinicals, Dilworth, Minnesota, United States
🇺🇸BioPharma Services USA Inc., Creve Coeur, Missouri, United States
🇨🇦BioPharma Services Inc., Toronto, Ontario, Canada
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 513
- Registration Number
- NCT03655236
- Locations
- 🇺🇸
Xenoscience Inc. - 21st Century Neurology, Phoenix, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences (UAMS) - Movement Disorders Clinic, Little Rock, Arkansas, United States
🇺🇸Keck Hospital of USC, Los Angeles, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next